title: Antisense gene suppression against human ICAM-1, ELAM-1, and VCAM-1 in cultured human umbilical vein endothelial cells.
abstract: Antisense gene suppression has been carried out for human ICAM-1, ELAM-1, and VCAM-1 in cultured human umbilical vein endothelial cells (HUVEC) stimulated by lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1 beta. A panel of antisense phosphorothioate oligodeoxyribonucleotides (PS-ODN), complementary to mRNA or pre-mRNA of these molecules, were tested for their gene suppression activity monitored by radioimmunoassay of the respective cell surface adhesion molecules. Sequences targeted by effective antisense PS-ODNs were located throughout the mRNA and pre-mRNA. "Hot spots" of gene suppression sites for each region were observed. Shift of the PS-ODN hybridizing site upstream or downstream by a few bases resulted in drastic change of gene suppression efficiency. In addition to translation arrest and RNase H activity, a third mechanism was proposed for antisense gene suppression, involving multiple binding sites for PS-ODN and the activities of RNase H and RNases other than RNase H. Suppression of ICAM-1, ELAM-1, or VCAM-1 in HUVEC by their antisense PS-ODNs resulted in the reduction of adhesion of monocytes and U937 to HUVEC. This may suggest cooperativity among the adhesion molecule pairs in endothelial-leukocyte adhesion, since decrease of a single adhesion molecule on EC surface significantly reduced cell-cell adherence.
authors.affiliation: Septic Shock Research Program, Naval Medical Research Institute, Bethesda, Maryland 20889-5607, USA.
authors.forename: C H
authors.initials: CH
authors.lastname: Lee
authors.forename: H H
authors.initials: HH
authors.lastname: Chen
authors.forename: G
authors.initials: G
authors.lastname: Hoke
authors.forename: J S
authors.initials: JS
authors.lastname: Jong
authors.forename: L
authors.initials: L
authors.lastname: White
authors.forename: Y H
authors.initials: YH
authors.lastname: Kang
mesh_terms: D001483:Base Sequence; D002448:Cell Adhesion / Q000235:genetics; D002478:Cells, Cultured; D016207:Cytokines / Q000494:pharmacology; D019040:E-Selectin / Q000187:drug effects / Q000235:genetics*; D004730:Endothelium, Vascular / Q000166:cytology*; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000187:drug effects / Q000235:genetics*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008969:Molecular Sequence Data; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D012333:RNA, Messenger / Q000235:genetics; D011863:Radioimmunoassay; D013489:Suppression, Genetic / Q000187:drug effects / Q000235:genetics*; D013873:Thionucleotides / Q000494:pharmacology; D014471:Umbilical Veins / Q000166:cytology; D019010:Vascular Cell Adhesion Molecule-1 / Q000187:drug effects / Q000235:genetics*
chemical_list: D016207:Cytokines; D019040:E-Selectin; D008070:Lipopolysaccharides; D016376:Oligonucleotides, Antisense; D012333:RNA, Messenger; D013873:Thionucleotides; D019010:Vascular Cell Adhesion Molecule-1; D018799:Intercellular Adhesion Molecule-1